University of San Diego

Digital USD
At Risk for Huntington's Disease

Department of History

11-1-2015

Might I finally take part in a Huntington’s disease clinical trials? An
update on the latest research
Kenneth P. Serbin
University of San Diego

Follow this and additional works at: https://digital.sandiego.edu/huntingtons
Part of the Nervous System Diseases Commons

Digital USD Citation
Serbin, Kenneth P., "Might I finally take part in a Huntington’s disease clinical trials? An update on the
latest research" (2015). At Risk for Huntington's Disease. 215.
https://digital.sandiego.edu/huntingtons/215

This Blog Post is brought to you for free and open access by the Department of History at Digital USD. It has been
accepted for inclusion in At Risk for Huntington's Disease by an authorized administrator of Digital USD. For more
information, please contact digital@sandiego.edu.

11/18/21, 12:25 PM

At Risk for Huntington's Disease: Might I finally take part in a Huntington’s disease clinical trial? An update on the latest research

More

Create Blog

Sign In

At Risk for Huntington's Disease
HD is a genetically caused brain disorder that causes uncontrollable bodily movements and robs
people's ability to walk, talk, eat, and think. The final result is a slow, ugly death. Children of parents
with HD have a 50-50 chance of inheriting the disease. There is no cure or treatment.
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Might I finally take part in a Huntington’s disease
clinical trial? An update on the latest research
In the 20 years of my family’s fight against Huntington’s disease – we
discovered my mom had HD the day after Christmas of 1995 – I felt this
past week for the first time that I might have a chance to avoid its
inevitable, mind-destroying symptoms.
On October 26, I learned about a new clinical trial aimed at rescuing brain
cells from the degeneration caused by Huntington’s.
Called “SIGNAL” (alternatively, VX15/2503 Treatment for Huntington’s
Disease), the trial will include asymptomatic carriers of the HD gene like
me who are close to predicted age of onset. Made by the Rochester, NYbased biotech company Vaccinex, VX15/2503 is a monoclonal antibody, a
type of molecule essential in molecular biological research.
Monoclonal antibodies are used in various forms by companies such as
Vaccinex to treat an increasing number of conditions such as cancer.
Vaccinex is also enrolling volunteers in a VX15/2503 trial for multiple
sclerosis. Vaccinex believes the very same compound might help alleviate a
host of other neurodegenerative diseases.
“The thought is that if we could give this drug early enough we can actually
slow the progression of Huntington’s, and that’s really exciting,” said Jody
Corey-Bloom, M.D., Ph.D., the director of the Huntington’s Disease
Society of America Center of Excellence for Family Services and Research
at the University of California, San Diego. She spoke to more than 50
people attending her annual HD research update presentation at the San
Diego support group on October 26.
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Jody Corey-Bloom, M.D., Ph.D. (photo by Gene Veritas)
Aiming to halt progression, delay onset
Dr. Corey-Bloom, who's provided research updates to the support group
since 2005, kicked off this year’s presentation with a review of the historic
news on October 19 that HD patients in England had received the first
dosing of an Isis Pharmaceuticals drug, ISIS-HTTRx, aimed at stopping the
disease at its genetic roots. ISIS-HTTRx is an antisense
oligonucleotide (ASO), an artificial strand of DNA (click here to read
more).
SIGNAL, initiated in June, is the “biggest” news on the HD clinical trial
field scene since the development of ASOs for use in HD, Dr. Corey-Bloom
said. SIGNAL marks the first ever use of a monoclonal antibody in an HD
clinical trial, she noted.
“So we’re not just treating motor signs,” she said of SIGNAL. “We’re
actually trying to slow the progression. And the reason is that this also
belongs to a class of drugs that blocks inflammation in the brain in animal
models. And so the hope is that we could either delay the onset or slow the
progression.”
VX15/2503 would help HD patients by reducing inflammation in the
brain. Scientists primarily from the lab of world-renowned HD expert
Michael Hayden, M.D., Ph.D., in collaboration with Vaccinex researchers,
published a breakthrough study in April in the journal Neurobiology of
Disease demonstrating how the use of a monoclonal antibody restored
health in HD mice.
Vaccinex is one of a growing number of biotech and pharmaceutical
companies that have delved into the search for HD treatments as research
has greatly expanded.
As the scientist-written HD research site HDBuzz noted last February,
other investigators are seeking ways to use other antibodies in the quest
for treatments.
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You can watch Dr. Corey-Bloom’s research update, which includes details
on numerous other hopeful projects, in the video below.

Update on Huntington's Disease
Research 2015: A Presentation by Dr.
Jody Corey-Bloom
from Gene Veritas

1:20:49

Update on Huntington's Disease Research 2015: A Presentation by Dr.
Jody Corey-Bloom from Gene Veritas on Vimeo.
Including presymptomatic volunteers
HD clinical trials have rarely included presymptomatic people because of
ethical concerns and the inability of science to measure a meaningful
effect.
However, SIGNAL includes presymptomatic individuals for several
reasons, in part because ways of detecting and interpreting the symptoms
have become ever more effective, Dr. Corey-Bloom explained.
“You have to be gene-positive, but you don’t even have to have a diagnosis,
because they believe that the drug itself is not going to hurt you,” she said,
adding that the current stage of the SIGNAL trial (Phase II) is primarily to
confirm its safety. (Later a Phase III would test the drug’s efficacy.)
SIGNAL will evaluate changes in participants’ brains using “very unique,
very high-level, high-quality imaging,” she said. “They’re doing very special
PET studies, and they’re also doing very special MRI studies, DTI,
diffusion tensor imaging, and so just a lot of very, very special techniques
that are being orchestrated by the Massachusetts General Hospital and
[researcher] Diana Rosas.”
Measuring the effects
One attendee asked specifically how a presymptomatic individual would
know whether onset had been delayed.
“I think the imaging data is going to be really compelling,” Dr. CoreyBloom said, noting that previous research has abundantly demonstrated
changes in the brain a decade or more before onset, as well as precise
measurements in those changes over time. “I think they’re going to be able
to tell that it isn’t declining the way people who aren’t being treated is
declining.[…] If you’re in the early stages and stay there, that would be
pretty impressive, too.”
Involving 36 volunteers at 13 sites across the country, SIGNAL will deliver
VX15/2503 intravenously once per month over twelve months in one
group and over 18 months in a second group. Dr. Corey-Bloom, whose
Center of Excellence enrolled the first patient in SIGNA, said that each
curehd.blogspot.com/2015/11/might-i-finally-take-part-in.html
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infusion would last about an hour. (Click here for the official details of the
trial, which will be administered by the Huntington Study Group [HSG]).
The HSG just completed its 2015 meeting, held October 21-24 in Tampa,
FL.
Further information about SIGNAL in the San Diego region is available at
858-246-1254.
Confidence, but….
I will call that number very soon to learn more about my eligibility and the
risks involved.
I tested positive for HD in 1999, and my mother died of the disorder in
2006 at the age of 68 after a two-decade battle. I’m almost 56, a stage
where my mother already had involuntary movements and suffered from
cognitive loss.
After attending the HD support group and seeing symptomatic friends, I’m
always worried about onset.
Dr. Corey-Bloom’s recap of the good news about the long-awaited Isis
clinical trial left me with a feeling of confidence that someday we will
defeat HD – but perhaps not in time to stop my onset. The Isis trial does
not include presymptomatic individuals, and, even if successful, it could
take five, ten, perhaps even 20 years for the approach to have a significant
impact on the disease.
Wishing for a ‘normal’ life
However, after hearing about SIGNAL for the first time, a flood of new
emotions began to pour over me.
I immediately felt hope for my friend Sharon Shaffer, my HD sister, and
other HD-affected individuals in the audience.

Sharon Shaffer and mother Fran Walker (photo by Gene Veritas)
I awoke at 3:45 the next morning full of energy. Unable to sleep again, I
worked on processing the video of Dr. Corey-Bloom’s talk.
curehd.blogspot.com/2015/11/might-i-finally-take-part-in.html
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“My 20th year attending support group – what a difference!” I wrote in my
notes. “Treatments and trials, people asking questions about real
scenarios, not just long-off hypotheses. PLUS: I learned of a trial that I can
maybe take part in and see symptoms prevented. What if my career can be
‘normal’ and my life ‘normal’?”
I’ve hardly ever had such positive thoughts, although I recognize that I am
extremely lucky to have remained asymptomatic this long.
Risks vs. benefits
My wife, who has seen so many of her own plans dashed because of HD,
was pleased to hear about SIGNAL.
She hopes every day for a treatment to save me, as well as others, from the
devastation she witnessed in my mother.
As I gather more information in the coming weeks, and if I am eligible to
participate in SIGNAL, I will weigh risks and benefits with her, my
physicians, and members of the HD community.
My immediate concerns: could VX15/2503 cause harmful side effects or
even trigger HD? Would participation somehow prevent me from taking
part in other trials in the future?
‘Unimaginable scenarios’
Regardless of my participation, I will follow this project with keen interest
– as surely will the rest of the HD community.
As with the Isis compound, there is no guarantee VX15/2503 will work.
However, it is yet another shot on goal in the search for effective
treatments. The more shots, the better the chance of success.
The HD community can now envision scenarios unimaginable 20 years
ago. That's significant progress.
Posted by Gene Veritas at 12:13 AM
Labels: antibody , clinical trials , Huntington's disease , inflammation , Isis
Pharmaceuticals , Jody Corey-Bloom , monoclonal antibody , mother , onset ,
presymptomatic , research , SIGNAL , symptoms , treatments , Vaccinex ,
VX15/2503

2 comments:
Unknown said...
Dear Ken,
SIGNAL is indeed exciting news! Gary and I continue to send
our most positive thoughts and warmest wishes your way. We
are sure that you will make the optimal decision as to whether
you will take part in the clinical trial, and we remain steadfastly
in your corner in your fight against HD! We are also convinced
that life is full of miracles and, with the aid of scientific
breakthroughs, you will be able to fend off this disease and be
the ultimate winner!
8:00 AM, November 02, 2015
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Hi Gene Veritas! How are you?
My name is Bruna and I am Brazilian, I have 23 years old. I
came to Toronto to study English. I live for years seeing the
disease. In addition to the great-uncles more I live with my
paternal grandmother, she has the disease and I have an aunt(I
have 2 cousins in the group of risk, they didn't do the test yet)
and my father was also diagnosed. So I live with this disease so
closer. And as you know I can have the disease but I didn't do
the test, even my sister. Despite being a sad disease, I could get
more closer to my family because of it. And see how much my
family is wonderful! As I will be a long time away and I saw the
opportunity to read more about the disease here in North
America and when I saw your blog and your history I felt really
thrilled. I'm sure that you are doing your best and helping the
world. I would like to say thank you for all the blog and
everything that I saw you've been doing. Also,if I could help
with something I would do with all my pleasure. I would love to
know more about how the things here are different for disease
from Brazil. My email is bruna_bernardino@hotmail.com |
bruna.a.bernardino@gmail.com. Thank you. (sorry if I wrote
some mistake in English haha learning)
8:29 PM, December 13, 2015
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